Egetis Therapeutics AB (EGTX) NPV

Sell:5.71 SEKBuy:5.77 SEKPrice decreased0.01 SEK (0.17%)

Prices delayed by at least 15 minutes
Sell:5.71 SEK
Buy:5.77 SEK
Change:Price decreased0.01 SEK (0.17%)
Deal now
Prices delayed by at least 15 minutes
Sell:5.71 SEK
Buy:5.77 SEK
Change:Price decreased0.01 SEK (0.17%)
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open5.71 SEK
Previous close5.77 SEK
Market capSEK 2.28bn
P/E ratio-99999.99
Volume678,250
Dividend yield0.00%
EMS-

Company information

Egetis Therapeutics AB (publ), formerly PledPharma AB (publ) is a Sweden-based pharmaceutical drug development company, focusing on projects in late-stage development for treatment of diseases with unmet medical needs ...

  • LocationSweden
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencySEK
  • Shares in issue395.16m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Balance sheet 2025

Total assetsSEK 639.10m
Total liabilitiesSEK 300.40m
Net debt-SEK 133.70m

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.